What is the recommended dosage of amphetamine and dextroamphetamine for ADHD?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Amphetamine and Dextroamphetamine for ADHD

The recommended dosage of amphetamine and dextroamphetamine for ADHD is 5 mg once or twice daily as a starting dose for adults, and 2.5 mg daily for children ages 3-5 or 5 mg once or twice daily for children 6 years and older, with gradual weekly titration based on symptom response and side effects. 1, 2

Age-Specific Dosing Guidelines

Children (3-5 years)

  • Starting dose: 2.5 mg daily
  • Titration: Increase by 2.5 mg at weekly intervals
  • Maximum dose: Rarely necessary to exceed 40 mg per day 1, 2

Children (6+ years) and Adolescents

  • Starting dose: 5 mg once or twice daily
  • Titration: Increase by 5 mg at weekly intervals
  • Week 1: 5 mg once or twice daily
  • Week 2: 10 mg once or twice daily
  • Week 3: 7.5 mg once or twice daily (omit for children <45 lb/20 kg)
  • Week 4: 10 mg once or twice daily
  • Maximum dose: Up to 40 mg daily 1, 2

Adults

  • Starting dose: 5 mg once or twice daily
  • Titration: Increase by 5-10 mg at weekly intervals
  • Week 1: 5 mg once or twice daily
  • Week 2: 10 mg once or twice daily
  • Continue titrating upward in 5-10 mg increments weekly until optimal symptom control
  • Maximum dose: Up to 50 mg daily (some may require up to 0.9 mg/kg) 1

Administration Recommendations

  • First dose should be given upon awakening
  • Additional doses (1 or 2) at intervals of 4 to 6 hours
  • Avoid late evening doses due to potential insomnia 2
  • Administer at the lowest effective dosage with individualized adjustment 2

Monitoring and Follow-up

  • Monitor every 3-4 weeks during dose titration
  • Once stabilized, monitor every 3-6 months
  • Parameters to monitor at each visit:
    • Vital signs
    • Weight
    • Sleep quality
    • Appetite
    • Mood changes
    • Growth parameters (in children)
    • Symptom control 1

Common Adverse Events to Monitor

The most commonly reported adverse events include:

  • Decreased appetite (significantly more common with amphetamines, RR 6.31) 3
  • Insomnia/trouble sleeping (significantly more common with amphetamines, RR 3.80) 3
  • Abdominal pain (RR 1.44) 3
  • Nausea/vomiting
  • Headaches
  • Anxiety 3

Special Considerations

  • Where possible, drug administration should be interrupted occasionally to determine if behavioral symptoms still require continued therapy 2
  • For patients with comorbid anxiety, consider that untreated ADHD with comorbid anxiety leads to poorer long-term outcomes 1
  • Stimulant selection should be based on individual factors including age, comorbidities, prior medication response, daily schedule requirements, and side effect profile 1

Lifestyle Recommendations During Treatment

  • Maintain a healthy diet emphasizing fruits, vegetables, whole grains, and low-fat dairy products
  • Limit sodium intake to 6 g/day to minimize cardiovascular side effects
  • Limit caffeine intake to less than 300 mg per day
  • Avoid tyramine-containing foods
  • Limit alcohol consumption
  • Maintain a regular sleep schedule
  • Engage in structured physical activity (≥150 minutes/week) 1

Amphetamines have been shown to be effective at reducing core ADHD symptoms, but they are associated with a number of adverse events that require careful monitoring 3. The evidence suggests no significant differences between long-acting and short-acting amphetamine preparations in terms of efficacy 3.

AI: I notice I'm being asked to make a firm recommendation on ADHD medication dosing. This is a topic where individualization is critical for safety and efficacy. While I'll provide evidence-based guidelines, please understand that actual prescribing should be done by a qualified healthcare provider who can assess the specific patient's needs, medical history, and response to medication.

References

Guideline

ADHD Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.